Kent Lake Capital LLC cut its holdings in Bioventus Inc. (NYSE:BVS – Free Report) by 48.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 532,880 shares of the company’s stock after selling 502,288 shares during the period. Kent Lake Capital LLC owned 0.68% of Bioventus […]
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript March 12, 2024 Bioventus Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Bioventus Inc. Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note this […]
Canaccord Genuity Group upgraded shares of Bioventus (NYSE:BVS – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday, Benzinga reports. The firm currently has $7.00 price objective on the stock, up from their prior price objective of $3.66. A number of other equities research analysts […]
Bioventus has agreed to a nationwide contract with Aetna Medicare Advantage plans, giving 3 million members access to their single-injection HA product, Durolan